$DHR (+0.63%) is now back at the level of 4 years ago and has been moving more or less sideways at this level for around 6 weeks. The development of the last few quarters was not good, but the forecast is positive again. EPS is expected to rise in the higher double-digit percentage range in Q1 and even more strongly in the further course of the year. Out of 18 analysts (yes, I know) there are 13x Buy/Strong Buy and 5x Hold.
Would the share now be a buy for you, or would you rather go for other candidates (which ones?). Of course, in the medical (technology) sector $ISRG (+1.9%) which have also recently corrected considerably, but are still valued much higher with a notoriously different chart trend. I'm planning to add further here anyway.
